Chemically cross-linked and grafted cyclodextrin hydrogels: From nanostructures to drug-eluting medical devices

Advanced Drug Delivery Reviews

Volumn 65, Issue 9, 2013, Pages 1188-1203

  Concheiro, Angel ^a   Alvarez Lorenzo, Carmen ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Affinity controlled release; Chemically cross linked cyclodextrins; Cyclodextrin; Drug device combination product; Drug eluting medical device; Hydrogel; Nanogel; Radiation induced grafting; Surface functionalization

Indexed keywords

ACRYLIC MONOMERS; BIOCOMPATIBILITY; BIOMEDICAL EQUIPMENT; COMPLEX NETWORKS; CYCLODEXTRINS; GRAFTING (CHEMICAL); HYDROGELS; HYDROPHILICITY; POLYMERIC IMPLANTS; TARGETED DRUG DELIVERY;

COMBINATION PRODUCTS; CONTROLLED RELEASE; MEDICAL DEVICES; NANOGELS; RADIATION-INDUCED GRAFTING; SURFACE FUNCTIONALIZATION;

CONTROLLED DRUG DELIVERY;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CAMPTOTHECIN; CARBOMER; CIPROFLOXACIN; CROSS LINKING REAGENT; CYCLODEXTRIN; DEXAMETHASONE; DIACYLCHLORIDE DERIVATIVE; DICLOFENAC; DIISOCYANATE DERIVATIVE; DOXORUBICIN; EPICHLOROHYDRINE; ESTRADIOL; ETHYLENEGLYCOL DIGLYCIDYLETHER; FLURBIPROFEN; HEXAMETHYLENE DIISOCYANATE; MACROGOL; MALEIC ANHYDRIDE BETA CYCLODEXTRIN; METHYLATED BETA CYCLODEXTRIN; NANOMATERIAL; POLY(N ISOPROPYLACRYLAMIDE); POLYMETHACRYLIC ACID; PROPRANOLOL; QUININE; RESVERATROL; SERTACONAZOLE; SUCCINYL CHLORIDE; TOLUENE DIISOCYANATE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BINDING AFFINITY; BIOCOMPATIBILITY; BLOOD BRAIN BARRIER; BLOOD VESSEL GRAFT; BONE IMPLANT; CATHETER; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONFORMATION; CONTROLLED RELEASE FORMULATION; COVALENT BOND; CROSS LINKING; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG ELUTING SINUS STENT; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; EMULSION; EVAPORATION; HUMAN; HYDROGEL; HYDROGEN BOND; HYDROPHILICITY; HYDROPHOBICITY; MEMBRANE PERMEABILITY; MICROCAPSULE; NONHUMAN; POLYMERIZATION; POROSITY; PRIORITY JOURNAL; PROSTHESIS; SOLUBILITY; STATIC ELECTRICITY; STRUCTURE ANALYSIS; VISCOELASTICITY;

AFFINITY-CONTROLLED RELEASE; CHEMICALLY CROSS-LINKED CYCLODEXTRINS; CYCLODEXTRIN; DRUG-DEVICE COMBINATION PRODUCT; DRUG-ELUTING MEDICAL DEVICE; HYDROGEL; NANOGEL; RADIATION-INDUCED GRAFTING; SURFACE FUNCTIONALIZATION;

CROSS-LINKING REAGENTS; CYCLODEXTRINS; DRUG DELIVERY SYSTEMS; EQUIPMENT AND SUPPLIES; HYDROGELS; NANOSTRUCTURES;

EID: 84884287044     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2013.04.015     Document Type: Review

References (195)

1. Loftsson T., Duchene D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 2007, 329:1-11.
2. Liu L., Guo Q.X. The driving forces in the inclusion complexation of cyclodextrins. J. Incl. Phenom. Macro. 2002, 42:1-14.
3. Thompson D.O. Cyclodextrins-enabling excipients: their present and future use in pharmaceuticals. Crit. Rev. Ther. Drug Carrier Syst. 1997, 14:1-104.
4. Loftsson T., Másson M., Sigurjónsdótirr J.F. Methods to enhance the complexation efficiency of cyclodextrins. STP Pharm. Sci. 1999, 9:237-242.
5. Perlovich G.L., Skar M., Bauer-Brandl A. Driving forces and the influence of the buffer composition on the complexation reaction between ibuprofen and HPβCD. Eur. J. Pharm. Sci. 2003, 20:197-200.
6. Szejtli J., Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur. J. Pharm. Biopharm. 2005, 61:115-125.
7. Brewster M.E., Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 2007, 59:645-666.
8. Loftsson T., Hreinsdóttir D., Másson M. Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 2005, 302:18-28.
9. Sawada S.I., Sasaki Y., Nomura Y., Akiyoshi K. Cyclodextrin-responsive nanogel as an artificial chaperone for horseradish peroxidasa. Colloid Polym. Sci. 2011, 289:685-691.
10. Lipinski C.A. Drug-like properties and the cause of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods 2000, 44:235-249.
11. Takagi T., Ramachandran C., Bermejo M., Yamashita S., Yu L.X., Amidon G.L. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol. Pharm. 2006, 3:631-643.
12. Davis M.E., Brewster M.E. Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. 2004, 3:1023-1035.
13. Irie E., Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 1997, 86:147-162.
14. Frijlink H.W., Eissens A.C., Schoonen A.J.M., Lerk C.F. The effects of cyclodextrins on drug absorption II. In vivo observations. Int. J. Pharm. 1990, 64:195-205.
15. Amdidouche D., Montassier P., Poelman M.C., Duchene D. Evaluation by laser Doppler velocimetry of the attenuation of tretinoin induced skin irritation by β-cyclodextrin complexation. Int. J. Pharm. 1994, 111:111-116.
16. Loftsson T., Brewster M.E., Másson M. Role of cyclodextrins in improving oral drug delivery. Am. J. Drug Deliv. 2004, 2:261-275.
17. Stella V.J., Rajewski R.A. Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 1997, 14:556-567.
18. Szente L., Szejtli J. Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Adv. Drug Deliv. Rev. 1999, 36:17-28.
19. Uekama K., Hirayama F., Irie T. Cyclodextrin drug carrier systems. Chem. Rev. 1998, 98:2045-2076.
20. Blanchard J., Proniuk S. Some important considerations in the use of cyclodextrins. Pharm. Res. 1999, 16:1796-1798.
21. Challa R., Ahuja A., Ali J., Khar R.K. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech 2005, 6:E329-E357. (Article 43).
22. Szejtli J. Past, present, and future of cyclodextrin research. Pure Appl. Chem. 2004, 76:1825-1845.
23. Uekama K. Design and evaluation of cyclodextrin-based drug formulation. Chem. Pharm. Bull. 2004, 52:900-915.
24. Loftsson T., Jarho P., Másson M., Jarvinen T. Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2005, 2:335-351.
25. Stella V.J., He Q. Cyclodextrins. Toxicol. Pathol. 2008, 36:30-42.
26. Otero-Espinar F., Torres-Labandeira J.J., Alvarez-Lorenzo C., Blanco-Méndez J. Cyclodextrins in drug delivery systems. J. Drug Deliv. Sci. Technol. 2010, 20:289-301.
27. Vyas A., Saraf S., Saraf S. Cyclodextrin based novel drug delivery systems. J. Incl. Phenom. Macrocycl. Chem. 2008, 62:23-42.
28. Uekama K., Horikawa T., Horiuchi Y., Hirayama F. In-vitro and in-vivo evaluation of delayed-release behavior of diltiazem from its o-carboxymethyl-o-ethyl-beta-cyclodextrin complex. J. Control. Release 1993, 25:99-106.
29. Ikeda Y., Kimura K., Hirayama F., Arima H., Uekama K. Controlled release of a water-soluble drug, captopril, by a combination of hydrophilic and hydrophobic cyclodextrin derivatives. J. Control. Release 2000, 66:271-280.
30. Zou M.J., Cheng G., Okamoto H., Hao X.H., An F., Cui F.D., Danjo K. Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates. World J. Gastroenterol. 2005, 11:7457-7460.
31. Ortiz Mellet C., Garcia Fernandez J.M., Benito J.M. Cyclodextrin-based gene delivery systems. Chem. Soc. Rev. 2011, 40:1586-1608.
32. Kulkarni A., DeFrees K., Hyun S.H., Thompson D.H. Pendant polymer:amino-beta-cyclodextrin:siRNA guest:host nanoparticles as efficient vectors for gene silencing. J. Am. Chem. Soc. 2012, 134:7596-7599.
33. Quaglia F., Ostacolo L., Mazzaglia A., Villari V., Zaccaria D., Sciortino M.T. The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs. Biomaterials 2009, 30:374-382.
34. Perret F., Parrot-Lopez H. Amphiphilic cyclodextrins: synthesis and characterization. Cyclodextrins in Pharmaceutics, Cosmetics and Biomedicine 2011, 199-233. Wiley, Hoboken, NJ. E. Bilensoy (Ed.).
35. Yameogo J.B.G., Geze A., Choisnard L., Putaux J.L., Gansane A., Sirima S.B., Semde R., Wouessidjewe D. Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers-I: Formulation, lyoavailability and in vitro antimalarial activity assessment. Eur. J. Pharm. Biopharm. 2012, 80:508-517.
36. Loethen S., Kim J.M., Thompson D.H. Biomedical applications of cyclodextrin based polyrotaxanes. Polym. Rev. 2007, 47:383-418.
37. Jing L.J., Feng Z., Jun L. Polyrotaxanes for applications in life science and biotechnology. Appl. Microbiol. Biotechnol. 2011, 90:427-443.
38. Simões S.M.N., Veiga F., Torres-Labandeira J.J., Ribeiro A.C.F., Sandez-Macho M.I., Concheiro A., Alvarez-Lorenzo C. Syringeable pluronic-α-cyclodextrin supramolecular gels for sustained delivery of vancomycin. Eur. J. Pharm. Biopharm. 2012, 80:103-112.
39. Zhang J.X., Ma P.X. Host-guest interactions mediated nano-assemblies using cyclodextrin-containing hydrophilic polymers and their biomedical applications. Nano Today 2010, 5:337-350.
40. Simões S.M.N., Veiga F., Torres-Labandeira J.J., Ribeiro A.C.F., Concheiro A., Alvarez-Lorenzo C. Poloxamine-Cyclodextrin-Simvastatin Supramolecular Systems Promote Osteoblast Differentiation of Mesenchymal Stem Cells. Macromol. Biosci 2013, (in press). 10.1002/mabi.201300017.
41. van de Manakker F., Vermonden T., van Nostrum C.F., Hennink W.E. Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications. Biomacromolecules 2009, 10:3157-3175.
42. Garcia-Fernandez M.J., Brackman G., Coenye T., Concheiro A., Alvarez-Lorenzo C. Antiseptic cyclodextrin-functionalized hydrogels and gauzes for loading and delivery of benzalkonium chloride. Biofouling 2013, 29:261-271.
43. Wang N.X., von Recum H.A. Affinity-based drug delivery. Macromol. Biosci. 2011, 11:321-332.
44. Lin C.C., Metters A.T. Hydrogels in controlled release formulations: network design and mathematical modeling. Adv. Drug Deliv. Rev. 2006, 58:1379-1408.
45. Kashyap N., Kumar N., Ravi Kumar M.N.V. Hydrogels for pharmaceutical and biomedical applications. Crit. Rev. Ther. Drug Carrier Syst. 2005, 22:107-150.
46. Peppas N.A., Bures P., Leobandung W., Ichikawa H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 2000, 50:27-46.
47. Kopecek J. Hydrogel biomaterials: a smart future?. Biomaterials 2007, 28:5185-5192.
48. Hoare T.R., Kohane D.S. Hydrogels in drug delivery: progress and challenges. Polymer 2008, 49:1993-2007.
49. Alvarez-Lorenzo C., Concheiro A. Intelligent drug delivery systems: polymeric micelles and hydrogels. Mini-Rev. Med. Chem. 2008, 8:1065-1074.
50. Prinda W., Krishnendu R. Disease-responsive drug delivery: the next generation of smart delivery devices. Curr. Drug Metab. 2012, 13:42-49.
51. Alvarez-Lorenzo C., Gomez-Amoza J.L., Martinez-Pacheco R., Souto C., Concheiro A. Microviscosity of hydroxypropylcellulose gels as a basis for prediction of drug diffusion rates. Int. J. Pharm. 1999, 180:91-105.
52. Barreiro-Iglesias R., Alvarez-Lorenzo C., Concheiro A. Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels. J. Control. Release 2001, 77:59-75.
53. Bibby D.C., Davies N.M., Tucker I.G. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int. J. Pharm. 2000, 197:1-11.
54. Pose-Vilarnovo B., Rodriguez-Tenreiro C., Rosa dos Santos J.F., Vazquez-Doval J., Concheiro A., Alvarez-Lorenzo C., Torres-Labandeira J.J. Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. J. Control. Release 2004, 94:351-363.
55. Crini G., Bertini S., Torri G., Naggi A., Sforzini D., Vecchi C., Janus L., Lekchiri Y., Morcellet M. Sorption of aromatic compounds in water using insoluble cyclodextrin polymers. J. Appl. Polym. Sci. 1998, 68:1973-1978.
56. Layre A.M., Gosselet N.M., Renard E., Sebille B., Amiel C. Comparison of the complexation of cosmetical and pharmaceutical compounds with γ-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin and water-soluble β-cyclodextrin-co-epichlorhydrin polymers. J. Incl. Phenom. Macro. 2002, 43:311-317.
57. Li J., Xiao H., Li J., Zhong Y.P. Drug carrier systems based on water-soluble cationic β-cyclodextrin polymers. Int. J. Pharm. 2004, 278:329-342.
58. Liu Y., Yang Y.W., Yang E.C., Guan X.D. Molecular recognition thermodynamics and structural elucidation of interactions between steroids and bridged bis(β-cyclodextrins)s. J. Org. Chem. 2004, 69:6590-6602.
59. Qian L., Guan Y., Xiao H. Preparation and characterization of inclusion complexes of a cationic β-cyclodextrin polymer with butylparaben or triclosan. Int. J. Pharm. 2008, 357:244-251.
60. Gazpio C., Sanchez M., Isasi J.R., Velaz I., Martin C., Martinez-Oharriz C., Zornoza A. Sorption of pindolol and related compounds by a β-cyclodextrin polymer: isosteric heat of sorption. Carbohydr. Polym. 2008, 71:140-146.
61. Alvarez-Lorenzo C., Moya-Ortega M.D., Loftsson T., Concheiro A., Torres-Labandeira J.J. Cyclodextrin-based hydrogels. Cyclodextrins in Pharmaceutics, Cosmetics and Biomedicine: Current and Future Industrial Applications 2011, 297-321. Wiley, Hoboken, NJ. E. Bilensoy (Ed.).
62. Cormack P.A.G., Elorza A.Z. Molecularly imprinted polymers: synthesis and characterization. J. Chromatogr. B 2004, 804:173-182.
63. Alvarez-Lorenzo C., Concheiro A. Molecularly imprinted gels and nano- and microparticles. Manufacture and applications. Smart Nano- and Microparticles 2006, 279-336. Kentus Books, London. R. Arshady, K. Kono (Eds.).
64. Kumar S.A., Khan M.I. Heterofunctional nanomaterials: fabrication, properties and applications in nanobiotechnology. J. Nanosci. Nanotechnol. 2010, 10:4124-4134.
65. Cabral Marques H.M. Applications of cyclodextrins. Thermodynamic aspects of cyclodextrin complexes. Rev. Port. Farm. 1994, 44:77-84.
66. Loftsson T., Brewster M.E. Pharmaceutical applications of cyclodextrins. J. Pharm. Sci. 1996, 85:1017-1025.
67. Rodriguez-Tenreiro C., Alvarez-Lorenzo C., Rodriguez-Perez A., Concheiro A., Torres-Labandeira J.J. Estradiol sustained release from high affinity cyclodextrin hydrogels. Eur. J. Pharm. Biopharm. 2007, 66:55-62.
68. Crini G., Morcellet M. Synthesis and applications of adsorbents containing cyclodextrins. J. Sep. Sci. 2002, 25:789-813.
69. Xu W.L., Liu J.D., Sun Y.P. Preparation of a cyclomaltoheptaose (β-cyclodextrin) cross-linked chitosan derivative via glyoxal or glutaraldehyde. Chin. Chem. Lett. 2003, 14:767-770.
70. Rodriguez-Tenreiro C., Alvarez-Lorenzo C., Rodriguez-Perez A., Concheiro A., Torres-Labandeira J.J. New cyclodextrin hydrogels cross-linked with diglycidylethers with a high drug loading and controlled release ability. Pharm. Res. 2006, 23:121-130.
71. Kobayashi N., Shirai H., Hojo N. Virtues of a poly-cyclodextrin for the de-aggregation of organic molecules in water. J. Polym. Sci. C: Polym. Lett. 1987, 27:191-195.
72. Crini G., Cosentino C., Bertini S., Naggi A., Torri G., Vecchi C., Janu L., Morcellet M. Solid state NMR spectroscopy study of molecular motion in cyclomaltoheptaose (beta-cyclodextrin) crosslinked with epichlorohydrin. Carbohydr. Res. 1998, 308:37-45.
73. Li J., Xiao H., Li J., Zhong Y.P. Drug carrier systems based on water-soluble cationic β-cyclodextrin polymers. Int. J. Pharm. 2004, 278:329-342.
74. Orprecio R., Evans C.H. Polymer-immobilized cyclodextrin trapping of model organic pollutants in flowing water streams. J. Appl. Polym. Sci. 2003, 90:2103-2110.
75. Crini G. Recent developments in polysaccharide-based materials used as adsorbents in wastewater treatment. Prog. Polym. Sci. 2005, 30:38-70.
76. Kim S.H., Ahn J., Kwak H.S. Crosslinking of beta-cyclodextrin on cholesterol removal from milk. Arch. Pharm. Res. 2004, 27:1183-1187.
77. Schneiderman E., Stalcup A.M. Cyclodextrins: a versatile tool in separation science. J. Chromatogr. B 2000, 745:83-102.
78. Thuaud N., Sebille B., Renard E. Insight into the chiral recognition of warfarin enantiomers by epichlorohydrin/β-cyclodextrin polymer-based supports: determination of stoichiometry and stability of warfarin/β-cyclodextrin polymer complexes. J. Biochem. Biophys. Methods 2002, 54:327-337.
79. Wang H.D., Chu L.Y., Song H., Yang J.P., Xie R., Yang M. Preparation and enantiomer separation characteristics of chitosan/β-cyclodextrin composite membranes. J. Membr. Sci. 2007, 297:262-270.
80. Scriba G.K.E. Cyclodextrins in capillary electrophoresis enantioseparations - Recent developments and applications. J. Sep. Sci. 2008, 31:1991-2011.
81. Velaz I., Isasi J.R., Sánchez M., Uzqueda M., Ponchel G. Structural characteristics of some soluble and insoluble β-cyclodextrin polymers. J. Incl. Phenom. Macro. 2007, 57:65-68.
82. Tsai H.A., Syu M.J. Synthesis of creatinine-imprinted poly(β-cyclodextrin) for the specific binding of creatinine. Biomaterials 2005, 26:2759-2766.
83. Fenyvesi E., Ujhazy A., Szejtli J., Pütter S., Gan T.G. Controlled release of drugs from CD polymers substituted with ionic groups. J. Incl. Phenom. Macro. 1996, 25:443-447.
84. Baille W.E., Huang W.Q., Nichifor M., Zhu X.X. Functionalized β-cyclodextrin polymers for the sorption of bile salts. J. Macromol. Sci. A 2000, 37:677-690.
85. Gil E.S., Li J., Xiao H., Lowe T.L. Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier. Biomacromolecules 2009, 10:505-516.
86. Gil E.S., Lowe T.L. Invention of polysaccharide-based nanoparticles for enhancing drug permeability across the blood brain barrier. NSTI Nanotechnol. Nanotechnol. Conf. Trade Show Tech. Proc. 2008, 2:379-381.
87. Zhang J.T., Huang S.W., Gao F.Z., Zhuo R.X. Novel temperature-sensitive, β-cyclodextrin-incorporated poly(N-isopropylacrylamide) hydrogels for slow release of drugs. Colloid Polym. Sci. 2005, 283:461-464.
88. Zhang J.T., Xue Y.N., Gao F.Z., Huang S.W., Zhuo R.X. Preparation of temperature-sensitive poly(N-isopropylacrylamide)/β-cyclodextrin-grafted polyethylenimine hydrogels for drug delivery. J. Appl. Polym. Sci. 2008, 108:3031-3037.
89. Liu Y.Y., Fan X.D., Kang T., Sun L.A. Cyclodextrin microgel for controlled release driven by inclusion effects. Macromol. Rapid Commun. 2004, 25:1912-1916.
90. Gao Z.W., Zhao X.P. Enhancing electrorheological behaviors with formation of beta-cyclodextrin supramolecular complex. Polymer 2003, 44:4519-4526.
91. Gao Z., Zhao X. Preparation and electrorheological characteristics of β-cyclodextrin-epichlorohydrin-starch polymer suspensions. J. Appl. Polym. Sci. 2004, 93:1681-1686.
92. Mocanu G., Vizitiu D., Carpov A. Cyclodextrin polymers. J. Bioact. Compat. Polym. 2001, 16:315-342.
93. Ozmen E.Y., Sezgin M., Yilmaz A., Yilmaz M. Synthesis of β-cyclodextrin and starch based polymers for sorption of azo dyes from aqueous solutions. Bioresour. Technol. 2008, 99:526-531.
94. Yamasaki H., Makihata Y., Fukunaga K. Preparation of crosslinked β-cyclodextrin polymer beads and their application as a sorbent for removal of phenol from wastewater. J. Chem. Technol. Biotechnol. 2008, 83:991-997.
95. Hishiya T., Shibata M., Kakazu M., Asanuma H., Komiyama M. Molecularly imprinted cyclodextrins as selective receptors for steroids. Macromolecules 1999, 32:2265-2269.
96. Hishiya T., Asanuma H., Komiyama M. Spectroscopic anatomy of molecular-imprinting of cyclodextrin. Evidence for preferential formation of ordered cyclodextrin assemblies. J. Am. Chem. Soc. 2002, 124:570-575.
97. Salmaso S., Semenzato A., Bersani S., Matricardi P., Rossi F., Caliceti P. Cyclodextrin/PEG based hydrogels for multi-drug delivery. Int. J. Pharm. 2007, 345:42-50.
98. Ooya T., Ichi T., Furubayashi T., Katoh M., Yui N. Cationic hydrogels of PEG crosslinked by a hydrolysable polyrotaxane for cartilage regeneration. React. Funct. Polym. 2007, 67:1408-1417.
99. Yu H., Feng Z., Zhang A., Sun L., Qian L. Synthesis and characterization of three-dimensional crosslinked networks based on self-assembly of α-cyclodextrins with thiolated 4-arm PEG using a three-step oxidation. Soft Matter 2006, 2:343-349.
100. Garcia-Zubiri I.X., Gonzalez-Gaitano G., Isasi J.R. Isosteric heats of sorption of 1-naphthol and phenol from aqueous solutions by β-cyclodextrin polymers. J. Colloid Interface Sci. 2007, 307:64-70.
101. Garcia-Zubiri I.X., Gonzalez-Gaitano G., Isasi J.R. Sorption models in cyclodextrin polymers: Langmuir, Freundlich, and a dual-mode approach. J. Colloid Interface Sci. 2009, 337:11-18.
102. Cesteros L.C., Gonzalez-Teresa R., Katime I. Hydrogels of β-cyclodextrin cross-linked by acylated poly(ethylene glycol): synthesis and properties. Eur. Polym. J. 2009, 45:674-679.
103. Oh J.K., Lee D.I., Park J.M. Biopolymer-based microgels/nanogels for drug delivery applications. Prog. Polym. Sci. 2009, 34:1261-1282.
104. Johnson J.A., Turro N.J., Koberstein J.T., Mark J.E. Some hydrogels having novel molecular structures. Prog. Polym. Sci. 2010, 35:332-337.
105. Marui Y., Kida T., Akashi M. Facile morphological control of cyclodextrin nano- and microstructures and their unique organogelation ability. Chem. Mater. 2010, 22:282-284.
106. Moya-Ortega M.D., Alvarez-Lorenzo C., Concheiro A., Loftsson T. Cyclodextrin-based nanogels for pharmaceutical and biomedical applications. Int. J. Pharm. 2012, 428:152-163.
107. Moya-Ortega M.D., Alvarez-Lorenzo C., Sigurdsson H.H., Concheiro A., Loftsson T. Cross-linked hydroxypropyl-β- and γ-cyclodextrin nanogels for drug delivery: physicochemical and loading/release properties. Carbohydr. Polym. 2012, 87:2344-2351.
108. Baruch-Teblum E., Mastai Y., Landfester K. Miniemulsion polymerization of cyclodextrin nanospheres for water purification from organic pollutants. Eur. Polym. J. 2010, 46:1671-1678.
109. Chen L., Zhu X., Yan D., He X. A straightforward method to synthesize cyclodextrin-based hyperbranched polymer from natural cyclodextrin. Polym. Prepr. 2003, 44:669-670.
110. Pariot N., Edwards-Levy F., Andry M.C., Levy M.C. Cross-linked β-cyclodextrin microcapsules: preparation and properties. Int. J. Pharm. 2000, 211:19-27.
111. Pariot N., Edwards-Levy F., Andry M.C., Levy M.C. Cross-linked β-cyclodextrin microcapsules. II. Retarding effect on drug release through semi-permeable membranes. Int. J. Pharm. 2002, 232:175-181.
112. Mocanu G., Mihai D., LeCerf D., Picton L., Moscovici M. Cyclodextrin-anionic polysaccharide hydrogels: synthesis, characterization, and interaction with some organic molecules (water pollutants, drugs, proteins). J. Appl. Polym. Sci. 2009, 112:1175-1183.
113. Komiyama M., Hirai H. Preparation of immobilized β-cyclodextrins by use of alkanediol diglycidyl ethers as cross-linking agents and their guest binding abilities. Polym. J. 1987, 19:773-775.
114. Yui N., Okano T., Sakurai Y. Inflammation responsive degradation of crosslinked hyaluronic acid gels. J. Control. Release 1992, 22:105-116.
115. Rodríguez R., Alvarez-Lorenzo C., Concheiro A. Cationic cellulose hydrogels: kinetics of the cross-linking process and characterization as pH-/ion-sensitive drug delivery systems. J. Control. Release 2003, 86:253-265.
116. Huang L.L.H., Lee P.C., Chen L.W., Hsieh K.H. Comparison of epoxides on grafting collagen to polyurethane and their effects on cellular growth. J. Biomed. Mater. Res. 1998, 39:630-636.
117. Lopez-Montero E., Rosa dos Santos J.F., Torres-Labandeira J.J., Concheiro A., Alvarez-Lorenzo C. Sertaconazole-loaded cyclodextrin-polysaccharide hydrogels for improved antifungal activity. Open Drug Deliv. J. 2009, 3:1-9.
118. Moya-Ortega M.D., Alvarez-Lorenzo C., Sigurdsson H.H., Concheiro A., Loftsson T. γ-Cyclodextrin hydrogels and semi-interpenetrating networks for sustained delivery of dexamethasone. Carbohydr. Polym. 2010, 80:900-907.
119. Blanco-Fernandez B., Lopez-Viota M., Concheiro A., Alvarez-Lorenzo C. Synergistic performance of cyclodextrin-agar hydrogels for ciprofloxacin delivery and antimicrobial effect. Carbohydr. Polym. 2011, 85:765-774.
120. Rodriguez-Tenreiro C., Diez-Bueno L., Concheiro A., Torres-Labandeira J.J., Alvarez-Lorenzo C. Cyclodextrin/carbopol micro-scale interpenetrating networks (ms-IPNs) for drug delivery. J. Control. Release 2007, 123:56-66.
121. Moya-Ortega M.D., Stefánsson E., Alvarez-Lorenzo C., Concheiro A., Loftsson T. Dexamethasone eye drops containing γ-cyclodextrins-based nanogels. CRS Nordic Chapter -Drug Delivery and Targeting, Reykjavik, Iceland 2012.
122. Cavalli R., Trotta F., Tumiatti W. Cyclodextrin-based nanosponges for drug delivery. J. Incl. Phenom. Macro. Chem. 2006, 56:209-213.
123. Ansari K.A., Vavia P.R., Trotta F., Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterization, stability, cytotoxicity and permeation study. AAPS PharmSciTech 2011, 12:279-286.
124. Li D., Ma M. New organic nanoporous polymers and their inclusion complexes. Chem. Mater. 1999, 11:872-874.
125. Torne S.J., Ansari K.A., Vavia R.P., Trotta F., Cavalli R. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges. Drug Deliv. 2010, 17:419-425.
126. Swaminathan S., Pastero L., Serpe L., Trotta F., Vavia P., Aquilano D., Trotta M., Zara G., Cavalli R. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur. J. Pharm. Biopharm. 2010, 74:193-201.
127. Trotta F. Cyclodextrin nanosponges and their applications. Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine 2011, 323-342. Wiley, Hoboken, NJ. E. Bilensoy (Ed.).
128. Lopez-Madruga E. From classical to living/controlled statistical free-radical copolymerization. Prog. Polym. Sci. 2002, 27:1879-1924.
129. Janus L., Carbonnier B., Morcellet M., Ricart G., Crini G., Deratani A. Mass spectrometric characterization of a new 2-hydroxypropyl-β-cyclodextrin derivative bearing methacrylic moities and its copolymerization with 1-vinyl-2-pyrrolidone. Macromol. Biosci. 2003, 3:198-209.
130. Harada A., Furue M., Nozakura S. Cyclodextrin-containing polymers. 1. Preparation of polymers. Macromolecules 1976, 9:701-704.
131. Harada A., Furue M., Nozakura S. Cyclodextrin-containing polymers. 2. Cooperative effects in catalysis and binding. Macromolecules 1976, 9:705-710.
132. Zhang J.T., Huang S.W., Zhuo R.X. Preparation and characterization of novel temperature sensitive poly(N-isopropylacrylamide-co-acryloyl-beta-cyclodextrin) hydrogels with fast shrinking kinetics. Macromol. Chem. Phys. 2004, 205:107-113.
133. Kettel M.J., Dierkes F., Schaefer K., Moeller M., Pich A. Aqueous nanogels modified with cyclodextrin. Polymer 2011, 52:1917-1924.
134. Asanuma H., Akiyama T., Kajiya K., Hishiya T., Komiyama M. Molecular imprinting of cyclodextrin in water for the recognition of nanometer-scaled guests. Anal. Chim. Acta 2001, 435:25-33.
135. Piletsky S.A., Andersson H.S., Nicholls I.A. Combined hydrophobic and electrostatic interaction-based recognition in molecularly imprinted polymers. Macromolecules 1999, 32:633-636.
136. Piletsky S.A., Andersson H.S., Nicholls I.A. On the role of electrostatic interactions in the enantioselective recognition of phenylalanine in molecularly imprinted polymers incorporating beta-cyclodextrin. Polym. J. 2005, 37:793-796.
137. Seo T., Kajihara T., Iijima T. The synthesis of poly(allylamine) containing covalently bound cyclodextrin and its catalytic effect in the hydrolysis of phenyl-esters. Macromol. Chem. 1987, 188:2071-2082.
138. Ramirez H.L., Cao R., Fragoso A., Torres-Labandeira J.J., Dominguez A., Schacht E.H., Baños M., Villalonga R. Improved anti-inflammatory properties for naproxen with cyclodextrin-grafted polysaccharides. Macromol. Biosci. 2006, 6:555-561.
139. Luzardo-Alvarez A., Antelo-Queijo A., Soto V.H., Blanco-Mendez J. Preparation and characterization of beta-cyclodextrin-linked chitosan microparticles. J. Appl. Polym. Sci. 2012, 123:3595-3604.
140. Liu Y.Y., Fan X.D., Gao L. Synthesis and characterization of β-cyclodextrin based functional monomers and its copolymers with N-isopropylacrylamide. Macromol. Biosci. 2003, 3:715-719.
141. Liu Y.Y., Fan X.D. Synthesis, properties and controlled release behaviors of hydrogel networks using cyclodextrin as pendant groups. Biomaterials 2005, 26:6367-6374.
142. Liu Y.Y., Fan X.D., Zhao Y.B. Synthesis and characterization of a poly(N-isopropylacrylamide) with β-cyclodextrin as pendant groups. J. Polym. Sci. Part A: Polym. Chem. 2005, 43:3516-3524.
143. Liu Y.Y., Yu Y., Tian W., Sun L., Fan X.D. Preparation and properties of cyclodextrin/PNIPAm microgels. Macromol. Biosci. 2009, 9:525-534.
144. Lee M.H., Yoon K.J., Ko S.H. Synthesis of a vinyl monomer containing β-cyclodextrin and grafting onto cotton fibber. J. Appl. Polym. Sci. 2001, 80:438-446.
145. Siemoneit U., Schmitt C., Alvarez-Lorenzo C., Luzardo A., Otero-Espinar F., Concheiro A., Blanco-Mendez J. Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability. Int. J. Pharm. 2006, 312:66-74.
146. Osawa T., Shirasaka K., Matsui T., Yoshihara S., Akiyama T., Hishiya T., Asanuma H., Komiyama M. Importance of the position of vinyl group on beta-cyclodextrin for the effective imprinting of amino acid derivatives and oligopeptides in water. Macromolecules 2006, 39:2460-2466.
147. Song S., Shirasaka K., Katayama M., Nagaoka S., Yoshihara S., Osawa T., Sumaoka J., Asanuma H., Komiyama M. Recognition of solution structures of peptides by molecularly imprinted cyclodextrin polymers. Macromolecules 2007, 40:3530-3532.
148. Liu Y.Y., Fan X.D. Synthesis and characterization of pH- and temperature-sensitive hydrogel of N-isopropylacrylamide/cyclodextrin based copolymer. Polymer 2002, 43:4997-5003.
149. Liu Y.Y., Fan X.D., Hu H., Tang Z.H. Release of chlorambucil from poly(N-isopropylacrylamide) hydrogels with β-cyclodextrin moieties. Macromol. Biosci. 2004, 4:729-736.
150. Shan T., Chen J., Yang L., Jie S., Qian Q. Radiation preparation and characterization of pH-sensitive hydrogel of acrylic acid/cyclodextrin based copolymer. J. Radioanal. Nucl. Chem. 2009, 279:75-82.
151. Wang Q., Li S., Wang Z., Liu H., Li C. Preparation and characterization of a positive thermoresponsive hydrogel for drug loading and release. J. Appl. Polym. Sci. 2009, 111:1417-1425.
152. Ma D., Zhang L.M., Yang C., Yan L. UV photopolymerized hydrogels with β-cyclodextrin moieties. J. Polym. Res. 2008, 15:301-307.
153. Lu D., Yang L., Zhou T., Lei Z. Synthesis, characterization and properties of biodegradable polylactic acid-β-cyclodextrin cross-linked copolymer microgels. Eur. Polym. J. 2008, 44:2140-2145.
154. Demir S., Kahraman M.V., Bora N., Apohan N.K., Ogan A. Preparation, characterization, and drug release properties of poly(2-hydroxyethyl methacrylate) hydrogels having β-cyclodextrin functionality. J. Appl. Polym. Sci. 2008, 109:1360-1368.
155. Zawko S.A., Schmidt C.E. Preparation of methacryoloyl-β-cyclodextrin monomer for hydrogel functionalization. Polym. Mater. Sci. Eng. 2006, 95:1022-1023.
156. Saito R., Okuno Y., Kobayashi H. Synthesis of polymers by template polymerization. I. Template polymerization of poly (methacrylic acid) with beta-cyclodextrin. J. Polym. Sci. Part A: Polym. Chem. 2001, 39:3539-3576.
157. Saito R., Yamaguchi K. Synthesis of bimodal methacrylic acid oligomers by template polymerization. Macromolecules 2003, 36:9005-9013.
158. Saito R., Yamaguchi K. Effect of guest compounds on template polymerization of multivinyl monomer of cyclodextrins. Macromolecules 2005, 38:2085-2092.
159. Hussain L.A., Dickens S.H., Bowen R.L. Shear bond strenght of experimental methacrylated beta-cyclodextrin-based formulations. Biomaterials 2005, 26:3973-3979.
160. Rosa dos Santos J.F., Couceiro R., Concheiro A., Torres-Labandeira J.J., Alvarez-Lorenzo C. Poly(hydroxyethyl methacrylate-co-methacrylated-β-cyclodextrin hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/release properties. Acta Biomater. 2008, 4:745-755.
161. Wintgens V., Layre A.M., Hourdet D., Amiel C. Cyclodextrin polymer nanoassemblies: strategies for stability improvement. Biomacromolecules 2012, 13:528-534.
162. Zilberman M., Elsner J.J. Antibiotic-eluting medical devices for various applications. J. Control. Release 2008, 130:202-215.
163. Couto D.S., Perez-Breva L., Saraiva P., Cooney C.L. Lessons from innovation in drug-device combination products. Adv. Drug Deliv. Rev. 2012, 64:69-77.
164. Alvarez-Lorenzo C., Bucio E., Burillo G., Concheiro A. Medical devices modified at the surface by g-ray grafting for drug loading and delivery. Expert Opin. Drug Deliv. 2010, 7:173-185.
165. Wu P., Grainger D.W. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 2006, 27:2450-2467.
166. Arruebo M., Vilaboa N., Santamaria J. Drug delivery from internally implanted biomedical devices used in traumatology and in orthopedic surgery. Expert Opin. Drug Deliv. 2010, 75:1-15.
167. Alvarez-Lorenzo C., Hiratani H., Concheiro A. Contact lenses for drug delivery: achieving sustained release with novel systems. Am. J. Drug Deliv. 2006, 4:131-151.
168. Alvarez-Lorenzo C., Yañez F., Concheiro A. Ocular drug delivery from molecularly-imprinted contact lenses. J. Drug Deliv. Sci. Technol. 2010, 20:237-248.
169. Cormio L., La Forgia P., La Forgia D., Siitonen A., Ruutu M. Bacterial adhesion to urethral catheters: role of coating materials and immersion in antibiotic solution. Eur. Urol. 2001, 40:354-358.
170. Wang Y., Burgess D.J. Drug-device combination products. Drug-device combination products. Delivery technologies and applications 2010, 3-28. Woodhead Publishing Limited and CRC Press LLC, Boca Raton, FL. A. Lewis (Ed.).
171. Lewis A.L. Enabling drug delivery from combination products. Drug-device combination products. Delivery technologies and applications 2010, 29-38. Woodhead Publishing Limited and CRC Press LLC, Boca Raton, FL. A. Lewis (Ed.).
172. Alvarez-Lorenzo C., Moya-Ortega M.D., Loftsson T., Concheiro A., Torres-Labandeira J.J. Cyclodextrin-based hydrogels. Cyclodextrins in Pharmaceutics, Cosmetics and Biomedicine 2011, 297-321. Wiley, Hoboken, NJ. E. Bilensoy (Ed.).
173. González-Chomón C., Concheiro A., Alvarez-Lorenzo C. Drug-eluting intraocular lenses. Materials 2011, 4:1927-1940.
174. Zhao X., Courtney J.M. Surface modification of polymeric biomaterials: utilization of cyclodextrins for blood compatibility improvement. J. Biomed. Mater. Res. 2008, 80A:539-553.
175. Zhao X., Courtney J.M. Novel "anchor modification" of polymeric biomaterial surfaces by the utilization of cyclodextrin inclusion complex supramolecules. J. Biomed. Mater. Res. 2009, 90A:282-291.
176. Wang C.X., Chen S.L. Anchoring β-cyclodextrin to retain fragrances on cotton by means of heterobifunctional reactive dyes. Color. Technol. 2004, 120:14-18.
177. Romi R., Lo Nostro P., Bocci E., Ridi F., Baglioni P. Bioengineering of a cellulosic fabric for insecticide delivery via grafted cyclodextrin. Biotechnol. Prog. 2005, 21:1724-1730.
178. Hebeish A., Fouda M.M.G., Hamdy I.A., El-Sawy S.M., Abdel-Mohdy F.A. Preparation of durable insect repellent cotton fabric: limonene as insecticide. Carbohydr. Polym. 2008, 74:268-273.
179. Rosa dos Santos J.F., Alvarez-Lorenzo C., Silva M., Balsa L., Couceiro J., Torres-Labandeira J.J., Concheiro A. Soft contact lenses functionalized with pendant cyclodextrins for controlled drug delivery. Biomaterials 2009, 30:1348-1355.
180. Rosa dos Santos J.F., Torres-Labandeira J.J., Matthijs N., Coenye T., Concheiro A., Alvarez-Lorenzo C. Functionalization of acrylic hydrogels with α-, ß- or γ-cyclodextrin modulates protein adsorption and antifungal delivery. Acta Biomater. 2010, 6:3919-3926.
181. Schofield W.C.E., McGettrick J.D., Badyal J.P.S. A substrate-independent approach for cyclodextrin functionalized surfaces. J. Phys. Chem. B 2006, 110:17161-17166.
182. Hirotsu T. Plasma graft polymerization of glycidyl methacrylate and cyclodextrin immobilization. Thin Solid Films 2006, 506-507:173-175.
183. Nava-Ortiz C.A.B., Burillo G., Bucio E., Alvarez-Lorenzo C. Modification of polyethylene films by radiation grafting of glycidyl methacrylate and immobilization of β-cyclodextrin. Radiat. Phys. Chem. 2009, 78:19-24.
184. Nava-Ortiz C.A.B., Alvarez-Lorenzo C., Bucio E., Concheiro A., Burillo G. Cyclodextrin-functionalized polyethylene and polypropylene as biocompatible materials for diclofenac delivery. Int. J. Pharm. 2009, 382:183-191.
185. Nava-Ortiz C.A.B., Burillo G., Concheiro A., Bucio E., Matthijs N., Nelis H., Coenye T., Alvarez-Lorenzo C. Cyclodextrin-functionalized biomaterials loaded with miconazole prevent Candida albicans biofilm formation in vitro. Acta Biomaterialia 2010, 6:1398-1404.
186. Abdel-Halim E.S., Fouda M.M.G., Hamdy L., Abdel-Modhy F.A., El-Sawy S.W. Incorporation of chlorohexidin diacetate into cotton fabrics grafted with glycidyl methacrylate and cyclodextrin. Carbohydr. Polym. 2010, 79:47-53.
187. Desmet G., Takács E., Wojnárovits L., Borsa J. Cellulose functionalization via high-energy irradiation-initiated grafting of glycidyl methacrylate and cyclodextrin immobilization. Radiat. Phys. Chem. 2011, 80:1358-1362.
188. Thatiparti T.R., Shoffstall A.J., von Recum H.A. Cyclodextrin-based device coatings for affinity-based release of antibiotics. Biomaterials 2010, 31:2335-2347.
189. Blanchemain N., Haulon S., Boschin F., Marcon-Bachari E., Traisnel M., Morcellet M., Hildebrand H.F., Martel B. Vascular prostheses with controlled release of antibiotics. Part 1: Surface modification with cyclodextrins of PET prostheses. Biomol. Eng. 2007, 24:149-153.
190. Martel B., Ruffin D., Weltrowski M., Lekchiri Y., Morcellet M. Water-soluble polymers and gels from the polycondensation between cyclodextrins and poly(carboxylic acid)s: a study of the preparation parameters. J. Appl. Polym. Sci. 2005, 97:433-442.
191. Martel B., Weltrowski M., Ruffin D., Morcellet M. Polycarboxylic acids as crosslinking agents for grafting cyclodextrins onto cotton and wool fabrics: study of the process parameters. J. Appl. Polym. Sci. 2002, 83:1449-1456.
192. Laurent T., Kacem I., Blanchemain N., Cazaux F., Neut C., Hildebrand H.F., Martel B. Cyclodextrin and maltodextrin finishing of a polypropylene abdominal wall implant for the prolonged delivery of ciprofloxacin. Acta Biomater. 2011, 7:3141-3149.
193. Blanchemain N., Karrout Y., Tabary N., Neut C., Bria M., Siepmann J., Hildebrand H.F., Martel B. Methyl-β-cyclodextrin modified vascular prosthesis: influence of the modification level on the drug delivery properties in different media. Acta Biomater. 2011, 7:304-314.
194. Jean-Baptiste E., Blanchemain N., Martel B., Neut C., Hildebrand H.F., Haulon S. Safety, healing and efficacy of vascular prostheses coated with hydroxypropyl-β-cyclodextrin polymer: experimental in vitro and animal studies. Eur. J. Vasc. Endovasc. Surg. 2012, 43:188-197.
195. Hoang Thi T.H., Chai F., Lepretre S., Blanchemain N., Martel B., Siepman F., Hildebrand H.F., Siepmann J., Flament M.P. Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gel. Int. J. Pharm. 2010, 400:74-85.